GlobalData on MSN
FDA clears Cepheid’s Xpert GI Panel for pathogen detection
The Xpert GI Panel identifies pathogens directly from stool specimens collected in Cary-Blair transport media.
Cepheid announced today that it has received FDA clearance for Xpert GI Panel, a multiplex PCR test designed to provide fast ...
Renowned molecular diagnostics provider Cepheid CPHD recently entered into a non-exclusive distribution agreement with Henry Schein Medical, the Medical business of one of the leading healthcare ...
Cepheid has introduced the GeneXpert ® 16-Site System at the 106th Annual Meeting of the American Society for Microbiology. The latest addition to Cepheid's GeneXpert ® family of real-time PCR devices ...
Tuberculosis has high prevalence in India. 26% of the cases of tuberculosis are here in India. There are many people that are affected but most importantly 850,000 people go undetected, or undiagnosed ...
The Xpert MTB/XDR test developed by the Foundation for Innovative New Diagnostics (FIND) and Cepheid Inc. quickly indicates whether a patient has a dangerous – and rapidly increasing – strain of ...
On November 4, 2022, the United States, through the United States Agency for International Development (USAID), donated 126 cutting-edge GeneXpert tuberculosis (TB) testing machines worth U.S. $3 ...
The World Health Organisation (WHO) continues to emphasise the critically important role testing plays in curbing the rampaging spread of the pandemic coronavirus (COVID-19). It describes testing as a ...
SRL Diagnostics sees that spinal TB diagnostics has now reached a new realm with access to advanced tests like Hains, GeneXpert, Quantiferon Gold and ADA which are highly sensitive to detect the ...
The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Nunavut's Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results